Florence Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$542K Hold
13,175
0.52% 10
2019
Q1
$531K Sell
13,175
-843
-6% -$33.8K 0.52% 9
2018
Q4
$581K Buy
+14,018
New +$582K 0.56% 7
2017
Q4
$706K Hold
20,553
0.7% 9
2017
Q3
$696K Hold
20,553
0.76% 8
2017
Q2
$637K Sell
20,553
-199
-1% -$6.28K 2.1% 8
2017
Q1
$674K Hold
20,752
2.27% 8
2016
Q4
$639K Buy
+20,752
New +$634K 0.7% 10

Other funds holding PFE

Florence Capital Advisors's PFE Position: Q2 2019 in Review

Florence Capital Advisors held its Pfizer (PFE) position steady in Q2 2019 at 13,175 shares worth $542K. The position accounts for 0.52% of the portfolio, ranked #10.

Florence Capital Advisors first reported a position in PFE in Q4 2016 and has held it in 8 quarters since. The position peaked at $706K in Q4 2017. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Florence Capital Advisors held 13,175 shares of Pfizer worth $542K as of Q2 2019.
  • Florence Capital Advisors left its Pfizer share count unchanged in Q2 2019.
  • Pfizer made up 0.52% of Florence Capital Advisors's portfolio in Q2 2019, its #10 holding.
  • Florence Capital Advisors first reported a position in Pfizer in Q4 2016 and has held it in 8 quarters since.
  • Florence Capital Advisors's Pfizer position peaked at $706K in Q4 2017.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Florence Capital Advisors's 13F filing for Q2 2019, filed 5 Feb 2020.